DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

BTIG Upgrades Globus Medical to Buy, Announces $46 Price Target

BTIG analyst Ryan Zimmerman upgrades Globus Medical (NYSE:GMED) from Neutral to Buy and announces $46 price target.

Benzinga · 03/18/2020 12:44

BTIG analyst Ryan Zimmerman upgrades Globus Medical (NYSE:GMED) from Neutral to Buy and announces $46 price target.